[Impact of anti-HLA antibodies on outcomes of allogeneic stem cell transplantation: a report by the SFGM-TC]

Pathol Biol (Paris). 2014 Aug;62(4):226-9. doi: 10.1016/j.patbio.2014.05.007. Epub 2014 Jun 25.
[Article in French]

Abstract

The role of anti-HLA antibodies in allogeneic stem cell transplantation setting is still unclear. In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC) set up its fourth annual series of workshops which brought together practitioners from all of its member centers. These workshops took place in September 2013 in Lille. This article offers the recommendations of the group that considered the impact that have anti-HLA antibodies on outcomes in allogeneic stem cell transplantation.

Keywords: Allogeneic stem cell transplantation; Allogreffe de cellules souches hématopoïétiques; Anti-HLA antibodies; Anticorps anti-HLA; Anticorps spécifique anti-HLA du donneur; Donor-specific antibody.

Publication types

  • English Abstract
  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • France
  • HLA Antigens / immunology*
  • Histocompatibility Testing
  • Humans
  • Isoantibodies / adverse effects*
  • Isoantibodies / analysis
  • Stem Cell Transplantation*
  • Tissue Donors
  • Transplantation, Homologous*
  • Treatment Outcome*

Substances

  • HLA Antigens
  • Isoantibodies